JRCT ID: jRCT1030220064
Registered date:17/05/2022
TRIUMPH Observational Study
Basic Information
| Recruitment status | Not Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Patients with HER2 positive mCRC |
| Date of first enrollment | 01/07/2022 |
| Target sample size | 30 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Overall survival |
|---|---|
| Secondary Outcome | Progression-free survival Duration of response Time to treatment failure |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | All patients who participated in the TRIUMPH study |
| Exclude criteria | Patients withdrawing consent for the TRIUMPH trial as of the end of April 2022 |
Related Information
| Primary Sponsor | Nakamura Yoshiaki |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Yoshiaki Nakamura |
| Address | 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba Chiba Japan 277-8577 |
| Telephone | +81-4-7133-1111 |
| triumph_core@east.ncc.go.jp | |
| Affiliation | National Cancer Center Hospital East |
| Scientific contact | |
| Name | Yoshiaki Nakamura |
| Address | 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba Chiba Japan 277-8577 |
| Telephone | +81-4-7133-1111 |
| triumph_core@east.ncc.go.jp | |
| Affiliation | National Cancer Center Hospital East |